Kostis WJ, Shetty M, Chowdhury YS, Kostis JB. ACE Inhibitor-Induced Angioedema: a Review. Curr Hypertens Rep. 2018;20:55. https://doi.org/10.1007/s11906-018-0859-x.

Article  CAS  PubMed  Google Scholar 

Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, et al. Incidence and Characteristics of Angioedema Associated With Enalapril. Arch Intern Med. 2005;165:1637–42. https://doi.org/10.1001/archinte.165.14.1637.

Article  CAS  PubMed  Google Scholar 

Sarkar P, Nicholson G, Hall G. Brief review: Angiotensin converting enzyme inhibitors and angioedema: anesthetic implications. Can J Anesthesia. 2006;53:994–1003. https://doi.org/10.1007/bf03022528.

Article  Google Scholar 

Lin RY, Shah SN. Increasing hospitalizations due to angioedema in the United States. Ann Allergy Asthma Immunol. 2008;101:185–92. https://doi.org/10.1016/s1081-1206(10)60208-6.

Article  PubMed  Google Scholar 

Beavers CJ, Dunn SP, Macaulay TE. The Role of Angiotensin Receptor Blockers in Patients with Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema. Ann Pharmacother. 2011;45:520–4. https://doi.org/10.1345/aph.1p630.

Article  CAS  PubMed  Google Scholar 

Haymore BR, DeZee KJ. Use Of Angiotensin Receptor Blockers After Angioedema With An Angiotensin-Converting Enzyme Inhibitor. Ann Allergy Asthma Immunol. 2009;103:83–84. https://doi.org/10.1016/s1081-1206(10)60151-2.

Article  PubMed  Google Scholar 

Toh S, Reichman ME, Houstoun M, Southworth MR, Ding X, Hernandez AF, et al. Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System. Arch Intern Med. 2012;172:1582–9. https://doi.org/10.1001/2013.jamainternmed.34.

Article  CAS  PubMed  Google Scholar 

Byrd JB, Touzin K, Sile S, Gainer JV, Yu C, Nadeau J, et al. Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema. Hypertension. 2008;51:141–7. https://doi.org/10.1161/hypertensionaha.107.096552.

Article  CAS  PubMed  Google Scholar 

Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol. 2003;3:311–7. https://doi.org/10.1016/s1567-5769(02)00162-5.

Article  CAS  PubMed  Google Scholar 

Byrd JB, Shreevatsa A, Putlur P, Foretia D, McAlexander L, Sinha T, et al. Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor–induced peritracheal edema. J Allergy Clin Immunol. 2007;120:403–8. https://doi.org/10.1016/j.jaci.2007.04.012.

Article  CAS  PubMed  Google Scholar 

Pavletic AJ. Late angio-oedema in patients taking angiotensin-converting-enzyme inhibitors. Lancet (Lond, Engl). 2002;360:493–4. https://doi.org/10.1016/s0140-6736(02)09661-7.

Article  Google Scholar 

Rasmussen E, Mey K, Bygum A. Angiotensin-converting Enzyme Inhibitor-induced Angioedema – A Dangerous New Epidemic. Acta Derm Venereol. 2014;94:260–4. https://doi.org/10.2340/00015555-1760.

Article  PubMed  Google Scholar 

Sato M, Takahashi M, Kario K. Critical angioedema induced by a renin angiotensin system blocker in the contemporary era of increasing heart failure: A case report and commentary. J Clin Hypertens. 2021;23:692–5. https://doi.org/10.1111/jch.14189.

Article  Google Scholar 

Loftus PA, Tan M, Patel G, Lin J, Helman S, Badhey A, et al. Risk factors associated with severe and recurrent angioedema: An epidemic linked to ACE‐inhibitors. Laryngoscope. 2014;124:2502–7. https://doi.org/10.1002/lary.24777.

Article  PubMed  Google Scholar 

Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme Inhibitors. Hypertension. 2008;51:1624–30. https://doi.org/10.1161/hypertensionaha.108.110270.

Article  CAS  PubMed  Google Scholar 

Elliott WJ. Incidence and Characteristics of Angioedema Associated With Enalapril Kostis JB, Kim HJ, Rusnak J, et al. (Univ of Medicine and Dentistry of New Jersey, New Brunswick; Bristol-Myers Squibb, Princeton, NJ; Creighton Univ, Omaha, Neb; et al.) Arch Intern Med 165:1637–1642, 2005§. Yearb Cardiol 2006; 2006: 80–81. https://doi.org/10.1016/s0145-4145(07)70043-6.

Duerr M, Glander P, Diekmann F, Dragun D, Neumayer H-H, Budde K. Increased Incidence of Angioedema with ACE Inhibitors in Combination with mTOR Inhibitors in Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2010;5:703–8. https://doi.org/10.2215/cjn.07371009.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA. Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema. Hypertension. 2009;54:516–23. https://doi.org/10.1161/hypertensionaha.109.134197.

Article  CAS  PubMed  Google Scholar 

Ghouse J, Ahlberg G, Andreasen L, Banasik K, Brunak S, Schwinn M, et al. Association of Variants Near the Bradykinin Receptor B2 Gene With Angioedema in Patients Taking ACE Inhibitors. J Am Coll Cardiol. 2021;78:696–709. https://doi.org/10.1016/j.jacc.2021.05.054.

Article  CAS  PubMed  Google Scholar 

Mathey CM, Maj C, Scheer AB, Fazaal J, Wedi B, Wieczorek D, et al. Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes. Front Genet. 2022;13:914376. https://doi.org/10.3389/fgene.2022.914376.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pare G, Kubo M, Byrd JB, McCarty CA, Woodard-Grice A, Teo KK, et al. Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genom. 2013;23:470–8. https://doi.org/10.1097/fpc.0b013e328363c137.

Article  CAS  Google Scholar 

Rasmussen ER, Hallberg P, Baranova EV, Eriksson N, Karawajczyk M, Johansson C, et al. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment. Pharmacogenom J. 2020;20:770–83. https://doi.org/10.1038/s41397-020-0165-2.

Article  CAS  Google Scholar 

Maroteau C, Siddiqui MK, Veluchamy A, Carr F, White M, Cassidy AJ, et al. Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker–Induced Angioedema. Clin Pharm Ther. 2020;108:1195–202. https://doi.org/10.1002/cpt.1927.

Article  CAS  Google Scholar 

Murat B, Jens G, Klaus S, Miriam H, Ulrich S, Nicole R, et al. A Randomized Trial of Icatibant in ACE-Inhibitor–Induced Angioedema. N Engl J Med. 2015;372:418–25. https://doi.org/10.1056/nejmoa1312524.

Article  Google Scholar 

Tomaszewski M, Zimmerli L, Charchar FJ, Dominiczak AF. Genetic information in the diagnosis and treatment of hypertension. Curr Hypertens Rep. 2006;8:309–16. https://doi.org/10.1007/s11906-006-0070-3.

Article  CAS  PubMed  Google Scholar